In a recently published study in the journal Nature Microbiology, researchers at Los Alamos National Laboratory show that computer simulations can accurately predict the transmission of HIV across populations, which could aid in preventing the disease.
The simulations were consistent with actual DNA data obtained from a global public HIV database, developed and maintained by Los Alamos. The archive has more than 840,000 published HIV sequences for scientific research.
"We looked for special genetic patterns that we had seen in the simulations, and we can confirm that these patterns also hold for real data covering the entire epidemic," said Thomas Leitner, a computational biologist at Los Alamos and lead author of the study.
HIV is particularly interesting to study in this manner, Leitner noted, as the virus mutates rapidly and constantly within each infected individual. The changing "genetic signatures" of its code provide a path that researchers can follow in determining the origin and time frame of an infection, and the computer simulations are now proven to be successful in tracking and predicting the virus's movements through populations.
The rapid mutational capability of the virus is useful for the epidemiological sleuthing, but also is one of the features that makes it so difficult to tackle with a vaccine.
Leitner and Ethan Romero-Severson, the study's co-author and a Los Alamos theoretical biologist, used phylogenetic methods, examining evolutionary relationships in the virus's genetic code to evaluate how HIV is transmitted. They found that certain phylogenetic "family tree" patterns correlated to the DNA data from 955 pairs of people, in which the transmitter and recipient of the virus were known.
"These HIV transmissions had known linkage based on epidemiological information such as partner studies, mother-to-child transmission, pairs identified by contact tracing, and criminal cases," the authors write.
The robust results from the study have led to a collaboration with Colorado and Michigan state health agencies. The researchers plan to develop public health computational tools to help the agencies to track the disease and allocate resources for targeted prevention campaigns. "We hope these tools will help to hinder new infections in the future," said Leitner.
Leitner said the cutting-edge modeling tools can also be used to predict the patterns of other rapidly evolving infectious diseases.
Los Alamos has a strong history in genetic data analysis, having been the site of the original GenBank project in 1979, known at the time as the Los Alamos Sequence Database and established by Walter Goad of the Theoretical Biology and Biophysics Group.
Source: Los Alamos National Laboratory
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.